These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8985281

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G, Ferro D, Basili S, Iuliano L, Camastra C, Giammarresi C, Santarone S, Rocca B, Landolfi R, Ciabattoni G, Cordova C, Violi F.
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [Abstract] [Full Text] [Related]

  • 23. Different tumor necrosis factor-alpha-associated leptin expression in rats with dimethylnitrosamine and bile duct ligation-induced liver cirrhosis.
    Lin SY, Chen WY, Chiu YT, Lee WJ, Wu HS, Sheu WH.
    Metabolism; 2005 Apr; 54(4):445-52. PubMed ID: 15798949
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Tyrosine metabolism in patients with liver disease.
    Levine RJ, Conn HO.
    J Clin Invest; 1967 Dec; 46(12):2012-20. PubMed ID: 6074004
    [Abstract] [Full Text] [Related]

  • 26. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT, Marigold JH, Thompson RP.
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [Abstract] [Full Text] [Related]

  • 27. Comparative analysis of plasma lipoprotein components assessed by ultracentrifugation in primary biliary cirrhosis and chronic hepatitis.
    Tacikowski T, Milewski B, Dzieniszewski J, Nowicka G, Walewska-Zielecka B.
    Med Sci Monit; 2000 Apr; 6(2):325-9. PubMed ID: 11208331
    [Abstract] [Full Text] [Related]

  • 28. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K, Wawrzynowicz-Syczewska M, Boroń-Kaczmarska A, Sych Z.
    Med Sci Monit; 2001 Apr; 7(5):962-5. PubMed ID: 11535942
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.
    Bittencourt PL, Farias AQ, Abrantes-Lemos CP, Goncalves LL, Goncalves PL, Magalhães EP, Carrilho FJ, Laudanna AA, Cançado EL.
    J Gastroenterol Hepatol; 2004 Aug; 19(8):873-8. PubMed ID: 15242489
    [Abstract] [Full Text] [Related]

  • 30. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R, Gundert-Remy U, Raedsch R, Sieg A, Stiehl A.
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [Abstract] [Full Text] [Related]

  • 31. [The impact of carnitine on serum ammonia concentration and lipid metabolism in patients with alcoholic liver cirrhosis].
    Łapiński TW, Grzeszczuk A.
    Pol Merkur Lekarski; 2003 Jul; 15(85):38-41. PubMed ID: 14593957
    [Abstract] [Full Text] [Related]

  • 32. Enhanced renal clearance of uric acid in hepatic cirrhosis.
    Higuchi T, Nakamura T, Uchino H.
    Isr J Med Sci; 1981 Nov; 17(11):1015-8. PubMed ID: 7319788
    [Abstract] [Full Text] [Related]

  • 33. [Clearance, reabsorption and excretion of free and bound L-carnitine in children].
    Karpowicz B, Kuchta G, Marczak E, Rutkowski B, Lysiak-Szydlowska W.
    Pol Tyg Lek; 1995 Sep; 50(36-39):42-4. PubMed ID: 8650031
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [Abstract] [Full Text] [Related]

  • 35. Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrhosis.
    Krahenbuhl S, Brass EP.
    Hepatology; 1991 Nov; 14(5):927-34. PubMed ID: 1937397
    [Abstract] [Full Text] [Related]

  • 36. Plasma and muscle carnitine in healthy and hemodialyzed children.
    Glöggler A, Bulla M, Puchstein C, Gulotta F, Fürst P.
    Child Nephrol Urol; 1991 Nov; 9(5):277-82. PubMed ID: 3271594
    [Abstract] [Full Text] [Related]

  • 37. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
    ter Borg PC, Schalm SW, Hansen BE, van Buuren HR, Dutch PBC Study Group.
    Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.